Investigators at the Cedars-Sinai Regenerative Medicine Institute have discovered eye abnormalities that may help reveal features of early-stage Alzheimer's disease. Using a novel laboratory rat model of Alzheimer's disease and high-resolution imaging techniques, researchers correlated variations of the eye structure, to identify initial indicators of the disease.
Alzheimer's disease is the leading cause of dementia, which is characterized by loss of memory and a progressive decline in cognitive function. To date, more than 26 million people are estimated to suffer from the disease and the number is expected to quadruple by 2050. Despite the disease being described over a century ago, treatment and understanding of the disease remain rather limited.
"Detecting changes in the brain that indicate Alzheimer's disease can be an extremely challenging task," said Shaomei Wang, MD, PhD, lead author of the study and an associate professor in the Regenerative Medicine Institute and Department of Biomedical Sciences. "By using the eye as a window to brain activity and function, we may be able to diagnose patients sooner and give them more time to prepare for the future. Options may include earlier enrollment in clinical trials, developing support networks and dealing with any financial and legal matters."
Using both animal models and postmortem human retinas from donors with Alzheimer's disease, researchers found changes in the retinal pigment epithelial layer, which harbors the supportive cells located in the back of the eye, and in the thickness of the choroidal layer that has blood vessels providing nutrients to the retina. Changes in these two regions were detected using sophisticated, state-of-the-art imaging and immunological techniques.
With high-resolution, microscopic imaging and visual acuity measurements, investigators were able to monitor tissue degeneration in the cell layer and vascular layer at the back of the eye, as well as decline in visual function, that were strongly associated with Alzheimer's disease.
"Greater magnitude in these eye abnormalities may mean a greater chance of a patient having Alzheimer's disease," said Alexander Ljubimov, PhD, director of the Eye Program within the Regenerative Medicine Institute and co-author of the study. "We found that a rat model showed similar signs to the human ailment in the eye. If true in a larger number of humans, these findings may be used to study Alzheimer's disease mechanisms and test potential drugs."
Though additional research is needed to investigate the mechanisms of these ocular changes in relation to changes in the brain, investigators hope to ultimately aid early diagnosis of Alzheimer's disease by studying the most approachable part of the central nervous system: the eye. Cedars-Sinai has been at the cutting edge of studies on the eye and Alzheimer's disease with a previous report showing amyloid plaques, a hallmark of Alzheimer's disease, also build up in the eye using a similar animal model of the disease.
"It is fascinating that the eye may provide such a window to the brain and eventually predict diseases such as Alzheimer's, although more human studies are now needed to confirm this animal work," said Clive Svendsen, PhD, director of the Cedars-Sinai Regenerative Medicine Institute and a co-author on the study. Other members of the Regenerative Medicine Institute Eye Program, include Yu Chun Tsai, PhD, a post-doctoral fellow; and Bin Lu, MD, PhD, and Sergey Girman, PhD, both project scientists.
Explore further: Research advancements made in diabetes-induced blindness
More information: Citation: Investigative Ophthalmology & Visual Science. 2014 January: Ocular Changes in TgF344-AD Rat Model of Alzheimer's disease.
Medical Xpress on facebook
Related Stories
Research advancements made in diabetes-induced blindness
Jan 15, 2014
Investigators at the Cedars-Sinai Regenerative Medicine Institute have identified new molecular abnormalities in the diabetic cornea that could contribute to eye problems in affected patients. With this new knowledge, investigators ...
Can the eyes help diagnose Alzheimer's disease?
Nov 13, 2013
An international team of researchers studying the link between vision loss and Alzheimer's disease report that the loss of a particular layer of retinal cells not previously investigated may reveal the disease's presence ...
Two parents with Alzheimer's disease? Disease may show up decades early on brain scans
Feb 12, 2014
People who are dementia-free but have two parents with Alzheimer's disease may show signs of the disease on brain scans decades before symptoms appear, according to a new study published in the February 12, 2014, online issue ...
Scientists design and test new approach for corneal stem cell treatments
Nov 27, 2013
Researchers in the Cedars-Sinai Regenerative Medicine Institute have designed and tested a novel, minute-long procedure to prepare human amniotic membrane for use as a scaffold for specialized stem cells that may be used ...
Potential biomarkers for the diagnosis of Alzheimer's disease
Jan 31, 2014
Researchers identify abnormal expression of genes, resulting from DNA relaxation, that can be detected in the brain and blood of Alzheimer's patients.
Recommended for you
New therapeutic target discovered for Alzheimer's disease
1 hour ago
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that ...
Chronic sleep disturbance could trigger onset of Alzheimer's
1 hour ago
People who experience chronic sleep disturbance—either through their work, insomnia or other reasons—could face an earlier onset of dementia and Alzheimer's, according to a new pre-clinical study by researchers at Temple ...
Research project aims at early diagnosis of memory disorders
4 hours ago
The PredictND project, started by European research organisations, aims at developing and validating new procedures for the earlier diagnosis of memory disorders and for detecting individuals at high risk of developing memory ...
Scientists slow development of Alzheimer's trademark cell-killing plaques
22 hours ago
University of Michigan researchers have learned how to fix a cellular structure called the Golgi that mysteriously becomes fragmented in all Alzheimer's patients and appears to be a major cause of the disease.
About one-quarter of patients with MCI progress to dementia
Mar 12, 2014
(HealthDay)—About 22 percent of patients with mild cognitive impairment (MCI) progress to dementia within three years, and depression symptoms modify the prognosis, according to a study published in the ...
Brain cell regeneration may alleviate symptoms of Alzheimer's disease
Mar 11, 2014
Alzheimer's disease is the most widespread degenerative neurological disorder in the world. Over five million Americans live with it, and one in three senior citizens will die with the disease or a similar ...
User comments
© Medical Xpress 2011-2014, Science X network
Investigators at the Cedars-Sinai Regenerative Medicine Institute have discovered eye abnormalities that may help reveal features of early-stage Alzheimer's disease. Using a novel laboratory rat model of Alzheimer's disease and high-resolution imaging techniques, researchers correlated variations of the eye structure, to identify initial indicators of the disease.
Alzheimer's disease is the leading cause of dementia, which is characterized by loss of memory and a progressive decline in cognitive function. To date, more than 26 million people are estimated to suffer from the disease and the number is expected to quadruple by 2050. Despite the disease being described over a century ago, treatment and understanding of the disease remain rather limited.
"Detecting changes in the brain that indicate Alzheimer's disease can be an extremely challenging task," said Shaomei Wang, MD, PhD, lead author of the study and an associate professor in the Regenerative Medicine Institute and Department of Biomedical Sciences. "By using the eye as a window to brain activity and function, we may be able to diagnose patients sooner and give them more time to prepare for the future. Options may include earlier enrollment in clinical trials, developing support networks and dealing with any financial and legal matters."
Using both animal models and postmortem human retinas from donors with Alzheimer's disease, researchers found changes in the retinal pigment epithelial layer, which harbors the supportive cells located in the back of the eye, and in the thickness of the choroidal layer that has blood vessels providing nutrients to the retina. Changes in these two regions were detected using sophisticated, state-of-the-art imaging and immunological techniques.
With high-resolution, microscopic imaging and visual acuity measurements, investigators were able to monitor tissue degeneration in the cell layer and vascular layer at the back of the eye, as well as decline in visual function, that were strongly associated with Alzheimer's disease.
"Greater magnitude in these eye abnormalities may mean a greater chance of a patient having Alzheimer's disease," said Alexander Ljubimov, PhD, director of the Eye Program within the Regenerative Medicine Institute and co-author of the study. "We found that a rat model showed similar signs to the human ailment in the eye. If true in a larger number of humans, these findings may be used to study Alzheimer's disease mechanisms and test potential drugs."
Though additional research is needed to investigate the mechanisms of these ocular changes in relation to changes in the brain, investigators hope to ultimately aid early diagnosis of Alzheimer's disease by studying the most approachable part of the central nervous system: the eye. Cedars-Sinai has been at the cutting edge of studies on the eye and Alzheimer's disease with a previous report showing amyloid plaques, a hallmark of Alzheimer's disease, also build up in the eye using a similar animal model of the disease.
"It is fascinating that the eye may provide such a window to the brain and eventually predict diseases such as Alzheimer's, although more human studies are now needed to confirm this animal work," said Clive Svendsen, PhD, director of the Cedars-Sinai Regenerative Medicine Institute and a co-author on the study. Other members of the Regenerative Medicine Institute Eye Program, include Yu Chun Tsai, PhD, a post-doctoral fellow; and Bin Lu, MD, PhD, and Sergey Girman, PhD, both project scientists.
Explore further: Research advancements made in diabetes-induced blindness
More information: Citation: Investigative Ophthalmology & Visual Science. 2014 January: Ocular Changes in TgF344-AD Rat Model of Alzheimer's disease.
Medical Xpress on facebook
Related Stories
Research advancements made in diabetes-induced blindness
Jan 15, 2014
Investigators at the Cedars-Sinai Regenerative Medicine Institute have identified new molecular abnormalities in the diabetic cornea that could contribute to eye problems in affected patients. With this new knowledge, investigators ...
Can the eyes help diagnose Alzheimer's disease?
Nov 13, 2013
An international team of researchers studying the link between vision loss and Alzheimer's disease report that the loss of a particular layer of retinal cells not previously investigated may reveal the disease's presence ...
Two parents with Alzheimer's disease? Disease may show up decades early on brain scans
Feb 12, 2014
People who are dementia-free but have two parents with Alzheimer's disease may show signs of the disease on brain scans decades before symptoms appear, according to a new study published in the February 12, 2014, online issue ...
Scientists design and test new approach for corneal stem cell treatments
Nov 27, 2013
Researchers in the Cedars-Sinai Regenerative Medicine Institute have designed and tested a novel, minute-long procedure to prepare human amniotic membrane for use as a scaffold for specialized stem cells that may be used ...
Potential biomarkers for the diagnosis of Alzheimer's disease
Jan 31, 2014
Researchers identify abnormal expression of genes, resulting from DNA relaxation, that can be detected in the brain and blood of Alzheimer's patients.
Recommended for you
New therapeutic target discovered for Alzheimer's disease
1 hour ago
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that ...
Chronic sleep disturbance could trigger onset of Alzheimer's
1 hour ago
People who experience chronic sleep disturbance—either through their work, insomnia or other reasons—could face an earlier onset of dementia and Alzheimer's, according to a new pre-clinical study by researchers at Temple ...
Research project aims at early diagnosis of memory disorders
4 hours ago
The PredictND project, started by European research organisations, aims at developing and validating new procedures for the earlier diagnosis of memory disorders and for detecting individuals at high risk of developing memory ...
Scientists slow development of Alzheimer's trademark cell-killing plaques
22 hours ago
University of Michigan researchers have learned how to fix a cellular structure called the Golgi that mysteriously becomes fragmented in all Alzheimer's patients and appears to be a major cause of the disease.
About one-quarter of patients with MCI progress to dementia
Mar 12, 2014
(HealthDay)—About 22 percent of patients with mild cognitive impairment (MCI) progress to dementia within three years, and depression symptoms modify the prognosis, according to a study published in the ...
Brain cell regeneration may alleviate symptoms of Alzheimer's disease
Mar 11, 2014
Alzheimer's disease is the most widespread degenerative neurological disorder in the world. Over five million Americans live with it, and one in three senior citizens will die with the disease or a similar ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment